|
시장보고서
상품코드
1786795
동물용 항감염제 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 동물 유형별, 약제 클래스별, 투여 경로별, 최종 사용자별, 지역별 시장 예측(2025-2034년)Veterinary Anti-infectives Market Size, Share, Trends, & Industry Analysis Report By Animal Type (Livestock and Companion), By Drug Class, By Route of Administration, By End User, and By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최근 조사에 따르면 동물용 항감염제 시장 규모는 2034년까지 157 억 1,000만 달러에 이를 것으로 예측됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
동물용 항감염제 시장은 축산업자와 반려동물 주인이 동물 감염을 관리하기 위해 신뢰할 수 있는 치료법을 요구하고 있기 때문에 세계적으로 강한 수요를 볼 수 있습니다. 동물의 건강, 식이 안전, 질병 예방에 대한 의식 증가가 항생제, 항바이러스제, 항진균제, 항기생충 제품의 사용을 가축과 반려동물 모두에서 촉진하고 있습니다.
이 시장의 기업은 치료 성과 및 편의성을 향상시키기 위해 제품 라인업을 확대하고 새로운 약물전달 시스템에 투자하고 있습니다. 동물 진단법의 진보 및 신흥 지역에서의 동물 의료 인프라의 성장은 시장 성장을 지원하고 효과적인 동물 건강 관리 솔루션에 대한 액세스를 늘리고 있습니다.
동물용 항감염제 시장 보고서 하이라이트
동물 유형별로는 소, 가금류, 돼지에서 박테리아, 바이러스, 기생충 감염이 널리 만연하고 있기 때문에 2024년에는 가축 부문이 시장을 독점했습니다.
약물 등급별로 항균제 부문은 2024년 시장을 독점했습니다. 이는 동물 유형에 관계없이 광범위한 동물 질병을 치료하는 광역 스펙트럼 솔루션의 채택이 증가하고 있기 때문입니다.
투여 경로별로 경구 부문은 2024년에 시장을 독점했습니다. 이것은 가축 생산에 있어서의 투여의 용이함으로 인하여, 약용 사료나 물 시스템이 효율적인 대량 치료를 가능하게 합니다.
최종 사용자별로는 첨단 진단 도구, 숙련된 수의사 전문가, 정비된 치료 인프라를 이용할 수 있기 때문에 동물 병원 부문이 2024년에 가장 큰 시장 점유율을 차지했습니다.
북미는 반려동물의 사육률이 높고 미국과 캐나다에서는 반려동물의 케어에 대한 수요가 왕성하기 때문에 2024년 세계의 동물용 항감염제 시장에서 대부분의 점유율을 차지했습니다.
아시아태평양은 동물 건강 관리 인프라가 개선되고 식량 안전과 가축 생산성이 중요해지기 때문에 예측 기간 동안 크게 성장할 것으로 예측됩니다.
세계 주요 시장 진출 기업으로는 Biogenesis Bago SA, Boehringer Ingelheim GmbH, Calier SA, Ceva Sante Animale SA, Dechra Pharmaceuticals Plc., Elanco Animal Health Incorporated, Intervet International BV(Merck 자회사), Merck & Co., Inc. Corporation, Vetoquinol SA, Virbac SA, Zoetis Inc., Bayer AG, Bimeda Animal Health Limited가 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 동물용 항감염제 시장 인사이트
- 시장 현황
- 동물용 항감염제 시장 역학
- 성장 촉진요인 및 기회
- 동물에서 인수 공통 감염증 및 감염병 급증
- 성장하는 동물용 헬스케어 인프라
- 성장 억제요인 및 과제
- 개발 도상 지역의 가격 감응성
- 성장 촉진요인 및 기회
- PESTEL 분석
- 동물용 항감염제 시장 동향
- 밸류체인 분석
제5장 세계의 동물용 항감염제 시장 : 동물 유형별
- 주요 조사 결과
- 서문
- 가축
- 반려동물
제6장 세계의 동물용 항감염제 시장 : 약제 클래스별
- 주요 조사 결과
- 서문
- 항균제
- 항바이러스제
- 항진균제
- 항기생충제
제7장 세계의 동물용 항감염제 시장 : 투여 경로별
- 주요 조사 결과
- 서문
- 경구
- 비경구
- 국소
제8장 세계의 동물용 항감염제 시장 : 최종 사용자별
- 주요 조사 결과
- 서문
- 동물병원
- 동물 클리닉
- 기타
제9장 세계의 동물용 항감염제 시장 : 지역
- 주요 조사 결과
- 서문
- 동물용 항감염제 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 동물 유형별(2020-2034년)
- 북미 : 약제 클래스별(2020-2034년)
- 북미 : 투여 경로별(2020-2034년)
- 북미 : 최종 사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 동물 유형별(2020-2034년)
- 유럽 : 약제 클래스별(2020-2034년)
- 유럽 : 투여 경로별(2020-2034년)
- 유럽 : 최종 사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 동물 유형별(2020-2034년)
- 아시아태평양 : 약제 클래스별(2020-2034년)
- 아시아태평양 : 투여 경로별(2020-2034년)
- 아시아태평양 : 최종 사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 동물 유형별(2020-2034년)
- 중동 및 아프리카 : 약제 클래스별(2020-2034년)
- 중동 및 아프리카 : 투여 경로별(2020-2034년)
- 중동 및 아프리카 : 최종사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 동물 유형별(2020-2034년)
- 라틴아메리카 : 약제 클래스별(2020-2034년)
- 라틴아메리카 : 투여 경로별(2020-2034년)
- 라틴아메리카 : 최종 사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제11장 기업 프로파일
- Biogenesis Bago SA
- Boehringer Ingelheim GmbH
- Calier SA
- Ceva Sante Animale SA
- Dechra Pharmaceuticals Plc.
- Elanco Animal Health Incorporated
- Intervet International BV
- Merck & Co., Inc.
- Norbrook Laboratories Ltd.
- Phibro Animal Health Corporation
- Vetoquinol SA
- Virbac SA
The veterinary anti-infectives market size is expected to reach USD 15.71 Billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Anti-infectives Market Size, Share, Trends, & Industry Analysis Report By Animal Type (Livestock and Companion), By Drug Class, By Route of Administration, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The veterinary anti-infectives market is witnessing strong global demand as livestock producers and pet owners seek reliable treatments to manage animal infections. Rising awareness about animal health, food safety, and disease prevention is driving the use of antibiotics, antivirals, antifungals, and antiparasitic products across both farm and companion animals.
Companies in the market are expanding product offerings and investing in new drug delivery systems to improve treatment outcomes and convenience. Advancements in veterinary diagnostics and growing veterinary care infrastructure in emerging regions, are supporting market growth and increasing access to effective animal healthcare solutions.
Veterinary Anti-infectives Market Report Highlights
Based on animal type, the livestock segment dominated the market in 2024, due to the widespread prevalence of bacterial, viral, and parasitic infections in cattle, poultry, and swine.
In terms of drug class, the antimicrobial segment dominated the market in 2024. This is owing to the rising adoption of broad-spectrum solutions for treating a wide range of animal diseases across species.
Based on route of administration, the oral segment dominated the market in 2024, due to ease of administration in livestock production, where medicated feed and water systems allow efficient mass treatment.
Based on end user, the veterinary hospitals segment held largest market share in 2024, owing to the availability of advanced diagnostic tools, skilled veterinary professionals, and well-developed treatment infrastructure.
North America accounted for the majority share in the global veterinary anti-infectives market in 2024, attributed to high pet ownership rates and strong demand for companion animal care in the U.S. and Canada.
Asia Pacific is expected to grow significantly during the forecast period, owing to improving animal healthcare infrastructure and rising emphasis on food safety and livestock productivity.
A few global key market players include Biogenesis Bago S.A., Boehringer Ingelheim GmbH, Calier S.A., Ceva Sante Animale S.A., Dechra Pharmaceuticals Plc., Elanco Animal Health Incorporated, Intervet International B.V. (a subsidiary of Merck & Co., Inc.), Merck & Co., Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corporation, Vetoquinol S.A., Virbac S.A., Zoetis Inc., Bayer AG, Bimeda Animal Health Limited.
Polaris Market Research has segmented the market report on the basis of animal type, drug class, route of administration, end user vertical, and region:
By Animal Type Outlook (Revenue, USD Billion, 2020-2034)
Livestock
Companion
By Drug Class Outlook (Revenue, USD Billion, 2020-2034)
Antimicrobial Agents
Antiviral Agents
Antifungal Agents
Antiparasitic Agents
By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)
Oral
Parenteral
Topical
By End User Vertical Outlook (Revenue, USD Billion, 2020-2034)
Veterinary Hospitals
Veterinary Clinics
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Veterinary Anti-infectives Market Insights
- 4.1. Veterinary Anti-infectives Market - Market Snapshot
- 4.2. Veterinary Anti-infectives Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Surge in Zoonotic and Infectious Diseases in Animals
- 4.2.1.2. Growing Veterinary Healthcare Infrastructure
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Price Sensitivity in Developing Regions
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Veterinary Anti-infectives Market Trends
- 4.6. Value Chain Analysis
5. Global Veterinary Anti-infectives Market, by Animal Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 5.3. Livestock
- 5.3.1. Global Veterinary Anti-infectives Market, by Livestock, by Region, 2020-2034 (USD Billion)
- 5.4. Companion
- 5.4.1.1. Global Veterinary Anti-infectives Market, by Companion, by Region, 2020-2034 (USD Billion)
6. Global Veterinary Anti-infectives Market, by Drug Class
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 6.3. Antimicrobial Agents
- 6.3.1. Global Veterinary Anti-infectives Market, by Antimicrobial Agents, by Region, 2020-2034 (USD Billion)
- 6.4. Antiviral Agents
- 6.4.1. Global Veterinary Anti-infectives Market, by Antiviral Agents, by Region, 2020-2034 (USD Billion)
- 6.5. Antifungal Agents
- 6.5.1. Global Veterinary Anti-infectives Market, by Antifungal Agents, by Region, 2020-2034 (USD Billion)
- 6.6. Antiparasitic Agents
- 6.6.1. Global Veterinary Anti-infectives Market, by Antiparasitic Agents, by Region, 2020-2034 (USD Billion)
7. Global Veterinary Anti-infectives Market, by Route of Administration
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 7.3. Oral
- 7.3.1. Global Veterinary Anti-infectives Market, by Oral, by Region, 2020-2034 (USD Billion)
- 7.4. Parenteral
- 7.4.1. Global Veterinary Anti-infectives Market, by Parenteral, by Region, 2020-2034 (USD Billion)
- 7.5. Topical
- 7.5.1. Global Veterinary Anti-infectives Market, by Topical, by Region, 2020-2034 (USD Billion)
8. Global Veterinary Anti-infectives Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 8.3. Veterinary Hospitals
- 8.3.1. Global Veterinary Anti-infectives Market, by Veterinary Hospitals, by Region, 2020-2034 (USD Billion)
- 8.4. Veterinary Clinics
- 8.4.1. Global Veterinary Anti-infectives Market, by Veterinary Clinics, by Region, 2020-2034 (USD Billion)
- 8.5. Others
- 8.5.1. Global Veterinary Anti-infectives Market, by Others, by Region, 2020-2034 (USD Billion)
9. Global Veterinary Anti-infectives Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Veterinary Anti-infectives Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Veterinary Anti-infectives Market - North America
- 9.3.1. North America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.3.3. North America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.4. North America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. Veterinary Anti-infectives Market - U.S.
- 9.3.5.1. U.S.: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.3.5.2. U.S.: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.3.5.3. U.S.: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.5.4. U.S.: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. Veterinary Anti-infectives Market - Canada
- 9.3.6.1. Canada: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4. Veterinary Anti-infectives Market - Europe
- 9.4.1. Europe: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.3. Europe: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.4. Europe: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. Veterinary Anti-infectives Market - UK
- 9.4.5.1. UK: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. Veterinary Anti-infectives Market - France
- 9.4.6.1. France: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.6.2. France: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.6.3. France: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.6.4. France: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. Veterinary Anti-infectives Market - Germany
- 9.4.7.1. Germany: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. Veterinary Anti-infectives Market - Italy
- 9.4.8.1. Italy: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. Veterinary Anti-infectives Market - Spain
- 9.4.9.1. Spain: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. Veterinary Anti-infectives Market - Netherlands
- 9.4.10.1. Netherlands: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. Veterinary Anti-infectives Market - Russia
- 9.4.11.1. Russia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. Veterinary Anti-infectives Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5. Veterinary Anti-infectives Market - Asia Pacific
- 9.5.1. Asia Pacific: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. Veterinary Anti-infectives Market - China
- 9.5.5.1. China: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.5.2. China: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.5.3. China: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.5.4. China: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. Veterinary Anti-infectives Market - India
- 9.5.6.1. India: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.6.2. India: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.6.3. India: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.6.4. India: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. Veterinary Anti-infectives Market - Malaysia
- 9.5.7.1. Malaysia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. Veterinary Anti-infectives Market - Japan
- 9.5.8.1. Japan: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. Veterinary Anti-infectives Market - Indonesia
- 9.5.9.1. Indonesia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. Veterinary Anti-infectives Market - South Korea
- 9.5.10.1. South Korea: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. Veterinary Anti-infectives Market - Australia
- 9.5.11.1. Australia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. Veterinary Anti-infectives Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.6. Veterinary Anti-infectives Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. Veterinary Anti-infectives Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. Veterinary Anti-infectives Market - UAE
- 9.6.6.1. UAE: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. Veterinary Anti-infectives Market - Israel
- 9.6.7.1. Israel: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. Veterinary Anti-infectives Market - South Africa
- 9.6.8.1. South Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. Veterinary Anti-infectives Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.7. Veterinary Anti-infectives Market - Latin America
- 9.7.1. Latin America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. Veterinary Anti-infectives Market - Mexico
- 9.7.5.1. Mexico: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. Veterinary Anti-infectives Market - Brazil
- 9.7.6.1. Brazil: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. Veterinary Anti-infectives Market - Argentina
- 9.7.7.1. Argentina: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. Veterinary Anti-infectives Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Biogenesis Bago S.A.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Boehringer Ingelheim GmbH
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Calier S.A.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Ceva Sante Animale S.A.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Dechra Pharmaceuticals Plc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Elanco Animal Health Incorporated
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Intervet International B.V.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Merck & Co., Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Norbrook Laboratories Ltd.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Phibro Animal Health Corporation
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Vetoquinol S.A.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Virbac S.A.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
샘플 요청 목록